Background In the pathogenesis of diabetic retinopathy, damaged retinal mitochondria accelerate apoptosis of retinal capillary cells, and regulation of oxidative stress by manipulating mitochondrial superoxide dismutase (SOD2) protects mitochondrial homeostasis and prevents the development of diabetic retinopathy. Diabetes also activates matrix metalloproteinase-9 (MMP-9), and activated MMP-9 damages retinal mitochondria. Recent studies have shown a dynamic DNA methylation process playing an important role in regulation of retinal MMP-9 transcription in diabetes; the aim of this study is to investigate the role of oxidative stress in MMP-9 transcription. Methods The effect of regulation of mitochondrial superoxide on DNA methylation of MMP-9 promoter region was investigated in retinal endothelial cells incubated in the presence or absence of a MnSOD mimetic MnTBAP, by quantifying the levels of 5 methyl cytosine (5mC) and hydroxyl-methyl cytosine (5hmC). The binding of DNA methylating, and of hydroxymenthylating enzymes (Dnmts and Tets, respectively), at MMP-9 promoter (by chromatin immunoprecipitation) was also evaluated. The in vitro results were confirmed in the retina of diabetic mice overexpressing SOD2. Results MnTBAP attenuated glucose-induced decrease in 5mC levels and increase on Dnmt1 binding at the MMP-9 promoter region. MnTBAP also ameliorated alterations in 5hmC levels and Tet binding, regulated MMP-9 transcription, and prevented mitochondrial damage. Similarly, mice overexpressing SOD2 were protected from diabetes-induced alteration in MMP-9 promoter methylation, and its transcription. Conclusions Thus, regulation of oxidative stress by pharmacologic/genetic approaches maintains retinal mitochondrial homeostasis by ameliorating epigenetic modifications in the MMP-9 promoter region.
Introduction
Oxidative stress remains as one of the major causative factors in the development of diabetic retinopathy; free radical production is increased and their removal is decreased in the retina and mitochondria are damaged, and this accelerates apoptosis of capillary cells [1, 2] . Regulation of oxidative stress by pharmacological means or by manipulating the enzyme responsible for scavenging mitochondrial superoxide, manganese superoxide dismutase (SOD2), protects mitochondrial homeostasis, and prevents the development of diabetic retinopathy in animal models [3, 4] . Diabetes also stimulates secretion of proteinases including matrix metalloproteinase-9 (MMP-9) [5] . The activity and transcription of MMP-9 is increased in diabetes in the retina and its capillary cells, and activated MMP-9 damages the mitochondria, releasing cytochrome c into the cytosol. Regulation of MMP-9 activation by genetic manipulations protects diabetes-induced mitochondrial dysfunction and apoptosis, and also prevents the development of diabetic retinopathy in mice [6, 7] . In addition to role of MMP-9 in increasing oxidative stress by damaging mitochondria, the presence of crucial cysteine residues within its DNA-binding domain also makes MMP-9 sensitive to oxidative stress [8, 9] . Furthermore, activation of redox-sensitive upstream signaling molecules, e.g. mitogen-activated protein kinase and nuclear transcriptional factor B (NF-kB), by increased oxidative stress also activates MMP-9 [6] .
Gene transcription, in addition to the transcription factors, is also modulated by epigenetic modifications, and diabetes enables many of these epigenetic modifications [10, 11] . Recent work has shown critical role of these epigenetic modifications in many diabetic complications including retinopathy and nephropathy [2, 12] . Diabetes hypomethylates H3K9 at the MMP-9 promoter, freeing up that lysine 9 (K9) for acetylation, and increased K9 acetylation facilitates the recruitment of transcription factors NF-kB and activator protein-1, AP-1, resulting in MMP-9 transcriptional activation. In addition, increase in oxidative stress inhibits deacetylase sirtuin 1(Sirt1), which hyperacetylates NF-kB and AP-1, increasing their binding at the MMP-9 promoter [13, 14] . MMP-9 transcription is also regulated by DNA methylation [15] . Our recent work has shown a major role of a dynamic DNA methylation process in regulating transcription of retinal MMP-9 in diabetes [16] . While DNA methyl transferases (Dnmts) add a methyl group to the cytosine forming methyl cytosine (5mC), Ten eleven translocases (Tets) hydroxymethylate that cytosine to form 5-hydroxymethyl cytosine, 5hmC [17] [18] [19] . The binding of these two redoxsensitive enzymes [20] , with opposing functions, is significantly increased at the MMP-9 promoter in diabetes [16] . However, the role of oxidative stress in regulation of DNA methylation machinery in modulating retinal MMP-9 transcription in diabetes remains unclear.
The goal of this study is to investigate the role of oxidative stress in retinal MMP-9 transcription in diabetes. Using retinal endothelial cells in culture, we have investigated the effect of regulation of mitochondrial superoxide on DNA methylation of MMP-9 promoter region by quantifying the levels of 5mC and 5hmC, and the binding of DNA methylating and hydroxymenthylating enzymes at MMP-9 promoter. The in vitro results are supported by analyzing the same parameters in the retina from diabetic mice genetically manipulated to overexpress mitochondrial superoxide dismutase, a manipulation that protects them from the development of diabetic retinopathy in these mice [2] .
Methods
Retinal endothelial cells, isolated from bovine retina, were cultured in Dulbecco's Modified Eagle medium containing 15% heat inactivated fetal bovine serum, 5% Nu-serum, 50 μg/mL heparin and 50 μg/mL endothelial cell growth supplement. Cells from 5-7th passage were incubated in 5 mM or 20 mM glucose media with/without a cell permeable manganese superoxide dismutase mimic, manganese (III) tetrakis (4-benzoic acid)porphyrin chloride (MnTBAP, 250 μM) [21] . For osmolarity control, cells were incubated in 20 mM mannitol, instead of 20 mM glucose.
Mice Hemizygous SOD2-Tg mice and their wildtype littermates were made diabetic by streptozotocin injection (55 mg/ kg BW) for four consecutive days (Tg-D and WT-D, respectively) and their age-matched normal SOD2-Tg and wildtype mice were used as controls (Tg-N and WT-N, respectively) [3, 21] . To avoid ketosis, diabetic mice received 01-02 IU insulin 4-6 times a week, and 6 months after induction of diabetes, mice were sacrificed by carbon dioxide asphyxiation. The treatment of the animals conformed to the Association for Research in Vision and Ophthalmology Resolution on the Use of Animals in Research, and all procedures performed involving animals were in accordance with the ethical standards of the institution.
Levels of 5hmC and 5hC were quantified in ∼250-500 ng sonicated gnomic DNA (DNeasy Blood & Tissue Kit, Qiagen, Germantown, MD, USA) using hydroxymethylated/ methylated DNA and Immunoprecipitation kits (hMeDIP/ MeDIP kits, EPIGENTEK, Farmingdale, NY, USA). 5hMC and 5mC were captured using a high affinity 5-hmC antibody and 5-mC monoclonal antibody respectively, and semiquantitative PCR was performed on DNA eluted from the plate using primers for MMP-9 promoter region (bovine: Fwd CTAGCCTGAGAAGGATGAAG and Rev TTCCTTGG GCTTCTGAGA; mouse Fwd CAGACGCCACAACA CTCCCA and Rev TCCTCTCCCTGCTCCACCTG). After denaturation at 95°C for 10 min and 35 cycles of denaturation at 95°C for 15 s, annealing was performed at 55°C for 30 s and extension at 72°C for 30 s. This was followed by 5 min at 72°C. The products were also analyzed on a 2% agarose gel, and visualized by ethidium bromide [16, 22] .
Chromatin Immunoprecipitation (ChIP) assay was performed to analyze interactions between Dnmt1/Tet2 and MMP-9 following the methods routinely performed in our laboratory [14, 22] . Sonicated, cross-linked sample (100 ∼ 120 μg) was incubated overnight with Tet2 or Dnmt1 antibody (Tet2-ab135087, Dnmt1-ab13537, Abcam, Cambridge, MA, USA). Immune-precipitated with non-immune IgG (Cell Signaling, Danvers, MA, USA) samples were used as antibody controls. Protein A/G agarose beads (EMD Millipore, Billerica, MA, USA) were employed to pull down the antibody-chromatin complexes. Protein-associated DNA was recovered by incubating the eluent at 65°C, purified by phenol extraction, and precipitated with ethanol, as reported previously [13, 22, 23] .
Immunofluorescence technique was employed to confirm binding of Dnmt1 and MMP-9 using the methods employed routinely [13] . Retinal endothelial cells, grown on coverslips in 5 mM or 20 mM glucose, in the presence or absence of MnTBAP, respectively, were fixed with 4% paraformaldehyde, and after permeabilization with 0.2% Triton X-100, blocked with 2% BSA for 1 h. The cells were the incubated with anti-rabbit MMP-9 antibody and antimouse-Dnmt1 antibody (catalog #s ab38898 and ab13537, respectively, Abcam). After blocking again with 10% goat serum, they were incubated with anti-rabbitDyLight 488 (green, MMP-9) and anti-mouse-Texas Red containing medium (blue; H-1500; Vector Lab), and imaged at 40X magnification using Zeiss ApoTome fluorescence microscope (Carl Zeiss Inc., Germany). Activities of Tet and Dnmt were estimated in nuclear fractions using EpiQuik™ Epigenase™ 5mC-Hydroxylase TET Activity/Inhibition and DNA Methyltransferase Activity/ Inhibition kits respectively (EPIGENTEK) [16, 24] .
Real-time quantitative PCR, SYBR Green-based, was performed to quantify the gene transcripts following the amplification program which included 50°C for 2 min and 95°C for 10 min-holding satge, 40 cycles of denaturation at 95°C for 15 s, annealing and extension at 60°C for 1 min, and 72°C for 5 min. Single peak in the melting curve was used to validate the reaction products. Cycle threshold (Ct) values from β-actin (bovine: Fwd CCTCTATGCCAACACAGTGC and Rev CATCGTACTCCTGCTTGCTG; mouse: Fwd CCTCTATGCCAACACAGTGC and Rev CATCGTAC TCCTGCTTGCTG) were used to normalize the values. Relative fold changes were calculated by considering the values obtained from cells in 5 mM glucose or normal mice as 1 [13, 22, 23] .
MMP-9 activity was quantified using an ELISA kit (Amersham, Buckinghamshire, UK), and the final product was quantified spectophotometrically at 405 nm using the specific peptide chromogen [7, 14] .
Statistical analysis Each measurement was made in duplicate, and assay was repeated three or more times. Data are expressed as mean ± SD. Statistical analysis was performed using the nonparametric Kruskal-Wallis test followed by Mann-Whitney test, and p < 0.05 was considered statistically significant.
Results
High glucose exposure of retinal endothelial cells, as expected, decreased 5mC levels in the MMP-9 promoter region [16] , and regulation of oxidative stress by MnTBAP ameliorated glucose-induced decrease in 5mC levels; the values obtained from cells incubated in high glucose in the presence and absence of MnTBAP were significantly different from each other (Fig. 1a) . In the same samples, glucose-induced increased Dnmt1 binding at the MMP-9 promoter region was also attenuated by MnTBAP (Fig. 1b) . However, supplementation of MnTBAP in 5 mM glucose medium did not alter either 5mC or Dnmt1 binding. Effect of MnTBAP on DNA methylation was further confirmed by immunoflurorescnce technique; as shown in Fig. 1c , glucose-induced increased co-localization of Dnmt1 and MMP-9 was significantly decreased by supplementation of MnTBAP in the incubation medium.
Since DNA methylation is a dynamic process and Tet can oxidize methyl cytosine to hydroxymethyl cytosine, and our recent study has shown that 5mC produced at MMP-9 promoter in hyperglycemic milieu undergoes hydroxymethylation [16] ; the effect of MnTBAP on hydroxylmethylation of MMP-9 promoter was determined. To investigate the role of oxidative stress on hydroxymethylation of MMP-9 promoter, 5hmC levels were quantified in the cells exposed to high glucose medium supplemented with MnTBAP. As shown in Fig. 2 (Fig. 3a & b) . In the same cell preparations, MnTBAP ameliorated increase in MMP-9 transcripts ( Fig. 3c) experienced by the cells in high glucose conditions, and also prevented mitochondrial DNA damage (Fig. 3d) (Fig. 3d) .
To further confirm our in vitro results in the in vivo model, retina from SOD2-Tg mice, diabetic for 6 months, was analyzed. The levels of 5mC in the MMP-9 promoter region, as expected, were 50% lower in the retina from diabetic mice compared to age-matched normal mice, and overexpression of SOD2 prevented diabetes-induced decrease in 5mC (Fig. 4a) . In the same retina samples, overexpression of SOD2 also prevented increase in Dnmt1 binding in the same MMP-9 promoter region (Fig. 4b) , and the values obtained from the retina of wildtype diabetic mice were significantly different from those obtained from SOD2-Tg diabetic or normal mice.
Consistent with our in vitro results, regulation of mitochondrial superoxide levels by overexpression of SOD2 also protected increase in 5hmC levels seen in the MMP-9 promoter in diabetic conditions. In the same animals, the binding of Tet2 at the MMP-9 promoter was also significantly lower in SOD2-Tg diabetic animals compared to age-matched wildtype diabetic animals ( Fig. 5a & b) . Similarly, overexpression of SOD2 also protected diabetes-induced increase in enzymatic activities of Dnmt and Tet, and ameliorated increase in MMP-9 gene expression; values obtained from SOD2-Tg diabetic mice were similar to those obtained from wildtype or SOD2-Tg normal mice (Fig. 6a-c) .
Discussion
Diabetic environment induces many metabolic abnormalities in the retina and its vasculature, e.g., inflammation and oxidative stress are elevated and protein kinase C is activated [1, 2, 25] . Retinal mitochondria become dysfunctional, their membranes leak out cytochrome C into the cytosol, and mtDNA is damaged. Amelioration of oxidative stress by pharmacological means or by genetic manipulation in animal models protect retina and its vasculature from such damage [2, 26] . Many genes implicated in the development of diabetic retinopathy are epigenetically modified, and DNA methylationhydroxymethylation machinery is activated [2, 16] . We have shown recently that the transcription of MMP-9, an enzyme implicated in retinal mitochondrial damage in the development of diabetic retinopathy, is regulated by a dynamic DNA methylation process [16] . Using both in vitro and in vivo models of diabetic retinopathy, here we provide exciting results demonstrating that the DNA methylation status of retinal MMP-9 promoter is under the control of oxidative stress. Amelioration of oxidative stress by chemical/genetic approaches regulates retinal MMP-9 transcription in diabetes via modulating DNA methylation of its promoter region, and this is mediated via protecting the diabetes-induced activation of the machinery responsible for maintaining the DNA methylation process. Thus, regulation of oxidative stress, prevents the activation of retinal MMP-9, which in turn protects mitochondrial homeostasis and, ultimately, the development of diabetic retinopathy. Methylation of the cytosine residues in CpG dinucleotides influences gene activity without changing the DNA sequences, and aberrant DNA methylation is associated with many pathological conditions, including cancer and diabetes [27] [28] [29] . Although there is a balance between reactive oxygen species (ROS) generation and their use/neutralization by enzymatic and non-enzymatic antioxidant systems, in pathological conditions, a redox imbalance is created by increased ROS production and/or reduced antioxidant reserve [2, 30] . ROS damage micro-and macromolecules, and in the pathogenesis of diabetic retinopathy, the levels of oxidatively modified DNA (8-hydroxyguanine, 8-OHdG) are elevated in the retina and its capillary cells [31] . Our results presented here show that the regulation of oxidative stress, despite reducing diabetes-induced increased binding of Dnmt1, prevents decrease in 5mC levels at the MMP-9 promoter, suggesting a role of oxidative stress in maintaining DNA methylation levels. In support, others have shown that although H 2 O 2 treatment can increase the binding of Dnmt1 [32] affects the methylation of adjacent sites, impeding further DNA methylation [33] . This suggests that attenuation of mitochondrial 8-OHdG accumulation by regulating mitochondrial damage could be assisting in ameliorating Dnmt1 binding. DNA methylation is a dynamic process, and hydroxylation of 5mC can significantly reduce methylation of the target cytosine causing DNA hypomethylation [34] . In diabetes, despite increased binding of Dnmt1 and decreased 5mC levels, retinal MMP-9 transcription is increased and 5hmC levels are elevated [16] . Here we show that regulation of oxidative stress, in addition to affecting DNA methylation of the MMP-9 promoter, also maintains its hydroxymethylation; addition of MnTBAP to the cells in high glucose condition, or overexpression of SOD2 in mice, prevents hyperglycemiainduced increase in 5hmC levels and recruitment of Tet2.
Methylation status of DNA is maintained by a group of enzymes with opposing functions, and the addition of a methyl group from S-adenosyl-methionine to cytosine is catalyzed by Dnmts resulting in formation of 5mC. Although there are three major Dnmts that are enzymatically active in mammals, Dnmt1 and Dnmt3a are the most active isoforms in neurons [35] . In the pathogenesis of diabetic retinopathy, Dnmt1 is the only isoform overexpressed in the retina and its capillary cells [16, 22] . Here we show that retinal Dnmt1 is also under the control of oxidative stress; regulation of mitochondrial superoxide levels by chemical or genetic approaches regulates activation of Dnmt1 seen in hyperglycemic milieu. Consistent with our results, others have shown that oxidative stress aff e c t s Dn m t s a n d al t e r s D N A m et h y l a t i on [ 33 ] . Hydroxymethyl marks on DNA are actively removed by Tets, and methyl group on the cytosine isoxidized to form, 5hmC [34] . Our data clearly show that, in addition to regulation of DNA methylation of MMP-9 promoter by oxidative stress, MnTBAP supplementation during high glucose incubation of retinal endothelial cells, or diabetic mice overexpressing SOD2, prevents increase in the formation of 5hmC at the promoter. This is accompanied by decrease in the binding of Tet2, suggesting a major role of oxidative stress in hydroxymethylation process. To strengthen this further, we show that the same in vitro/in vivo manipulations of MnSOD also ameliorate diabetes-induced increase in retinal Tet activity. Consistent with this, Tets are activated under high oxygen conditions by alpha ketoglutarate, a cofactor produced in the citric acid cycle [36] , and N-acetyl-l-cysteine, a known antioxidant, diminishes global DNA hypomethylation [37] .
Thus, regulation of oxidative stress by chemical/genetic approaches, which prevents hyperglycemia-induced accelerated capillary cell apoptosis, and the development of diabetic retinopathy [3, 4] , also regulates the DNA methylatinghydroxymenthylating machinery. This prevents epigenetic modifications of the MMP-9 promoter, and helps further in maintaining retinal mitochondrial homeostasis.
